respiratory diseases

COPD
Biotech

AZ's 'science success story' with tozorakimab plays out in full

With detailed results on a ph. 3 win, AstraZeneca has secured an FDA priority review for what it believes could become a flagship biologic in COPD.
Fraiser Kansteiner Sep 8, 2026 10:50am
three triple doors opportunity cracked open ajar

GSK picks 1st biotech partners under $7B Flagship pact

Nov 20, 2025 6:30am
Compressor inhaler with childs mask and pocket device for asthmatics on background of table

Roche pens $1B deal for respiratory bispecific from China

Oct 30, 2025 5:04am
A close-up view of a handshake between a doctor and a professional symbolizing agreement and business relations

GSK and Cambridge scientists join forces in $65M immune R&D deal

Oct 22, 2024 3:30pm
Close-up of female doctor with a nasal spray

Nasal spray protects mice from deadly flu

Oct 2, 2024 8:54am
A doctor with a graphic representation of the lungs

GSK's long-acting asthma drug halved attacks in phase 3

Sep 9, 2024 9:30am